COVID-19 pandemic impact on severe asthma patients care in Europe
Research type
Research Study
Full title
COVID-19 pandemic impact on severe asthma patients care in Europe
IRAS ID
295011
Contact name
Matthew Masoli
Contact email
Sponsor organisation
Royal Devon & Exeter Hospital Trust
Duration of Study in the UK
0 years, 3 months, 0 days
Research summary
Key aim of this study is to describe how the COVID-19 pandemic changed severe asthma care and how this impacted on patients in order to inform physicians on what aspects re-organization of care could be improved in case of a second wave. The specific aims are:
1. to describe from the perspective of physicians any changes in organization of care, involvement of other disciplines, availability of biologic treatments and how they were administered, deployment of new ICT facilities, how physicians were guided to act and possible impact on future organization of care.2. to describe from the perspective of patients any changes in access to care and/or (biologic) treatments, and how this has altered patients’ perceptions of satisfaction with care, asthma symptoms and emotions.
To achieve the goal, the patient advisory group is part of the study team and have a key role in the study design, analysis plan, and data dissemination plan.
REC name
HSC REC A
REC reference
21/NI/0075
Date of REC Opinion
20 Apr 2021
REC opinion
Favourable Opinion